Hemostasis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hemostasis stocks.

Hemostasis Stocks Recent News

Date Stock Title
May 10 HAE Haemonetics Corp (HAE) Fiscal 2024 Earnings: Aligns with EPS Projections, Reveals Robust ...
May 10 HAE Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand
May 10 HAE Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript
May 9 HAE Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say
May 9 HAE Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates
May 9 HAE Haemonetics Non-GAAP EPS of $0.90 beats by $0.01, revenue of $343.29M beats by $13.82M
May 9 HAE Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
May 9 HAE Insider Sale at Haemonetics Corp (HAE): EVP, Chief Technology Officer Anila Lingamneni Sells ...
May 8 HAE Haemonetics Q4 2024 Earnings Preview
May 8 HAE PHG vs. HAE: Which Stock Is the Better Value Option?
May 7 TTOO T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
May 7 TTOO T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript
May 7 TTOO Q1 2024 T2 Biosystems Inc Earnings Call
May 7 TTOO T2 Biosystems Inc (TTOO) Q1 2024 Earnings Call Transcript Highlights: Revenue Growth Amidst ...
May 7 TTOO T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call Transcript
May 6 TTOO T2 Biosystems enters into distribution agreement in Qatar
May 6 TTOO T2 Biosystems GAAP EPS of -$2.66, revenue of $2.06M
May 6 TTOO T2 Biosystems Announces First Quarter 2024 Financial Results
May 6 TTOO T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
May 6 TTOO T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
Hemostasis

Hemostasis or haemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing. This involves coagulation, blood changing from a liquid to a gel. Intact blood vessels are central to moderating blood's tendency to form clots. The endothelial cells of intact vessels prevent blood clotting with a heparin-like molecule and thrombomodulin and prevent platelet aggregation with nitric oxide and prostacyclin. When endothelial injury occurs, the endothelial cells stop secretion of coagulation and aggregation inhibitors and instead secrete von Willebrand factor which initiate the maintenance of hemostasis after injury. Hemostasis has three major steps: 1) vasoconstriction, 2) temporary blockage of a break by a platelet plug, and 3) blood coagulation, or formation of a fibrin clot. These processes seal the hole until tissues are repaired.

Browse All Tags